Group 1 - The core point of the article is that Gilead Sciences (1672.HK) experienced a significant drop of over 10% in its stock price after reaching a historical high, following a share placement announcement [1] - The company conducted a share placement at a price of HKD 16.45 per share, which represents a discount of 9.91% compared to the previous closing price of HKD 18.26 [2] - The total amount raised from the share placement is approximately HKD 474 million, with a net amount of HKD 468 million, of which about 90% is intended for clinical trials related to obesity treatments [1] Group 2 - The controlling shareholder, Wu Jinzi, sold 52.4 million shares and subscribed to 28.82 million new shares, realizing approximately HKD 388 million [1] - Following the completion of the placement and subscription, the controlling shareholder's stake will decrease from 62.21% to 58.03% [1]
港股异动丨歌礼制药大跌超10%，先旧后新折价配股，大股东减持套现3.9亿